Home » Novartis Sues Alvogen to Block Generic Dementia Patch
Novartis Sues Alvogen to Block Generic Dementia Patch
Novartis AG slapped generic-drug maker Alvogen Group with a lawsuit in Delaware, accusing Alvogen of infringing two patents by seeking U.S. regulatory approval to make and sell generic versions of the Exelon patch, a dementia treatment.
Law360
Law360
Upcoming Events
-
07May
-
14May
-
30May